Cargando…

Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism

The burden of obesity and associated cardiometabolic diseases has been considered as an important risk factor for lupus patients. Therefore, whether obesity is involved in the over-activation of autoimmune response has attracted more and more attention. Hydroxychloroquine is a synthetic antimalarial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Xin, Zhou, Zhuo-Chao, Niu, Rui, Su, Yu-Tong, Sun, Yue, Liu, Hong-Lei, Teng, Jia-Lin, Ye, Jun-Na, Shi, Hui, Yang, Cheng-De, Cheng, Xiao-Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689966/ https://www.ncbi.nlm.nih.gov/pubmed/31427967 http://dx.doi.org/10.3389/fphar.2019.00855

Ejemplares similares

Ginseng-plus-Bai-Hu-Tang ameliorates diet-induced obesity, hepatic steatosis, and insulin resistance in mice
por: Lu, Hsu-Feng, et al.
Publicado: (2020)

miR-378b Regulates Insulin Sensitivity by Targeting Insulin Receptor and p110α in Alcohol-Induced Hepatic Steatosis
por: Li, Yuan-yuan, et al.
Publicado: (2020)

Immune and Metabolic Regulation Mechanism of Dangguiliuhuang Decoction against Insulin Resistance and Hepatic Steatosis
por: Cao, Hui, et al.
Publicado: (2017)

Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats via a GLP-1R Dependent AMPK Pathway
por: Zhou, Rui, et al.
Publicado: (2021)

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
por: Xu, Jing, et al.
Publicado: (2009)

Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway
por: Li, Liuran, et al.
Publicado: (2021)

miR-203 Inhibits Alcohol-Induced Hepatic Steatosis by Targeting Lipin1
por: Cheng, Xiao-Yu, et al.
Publicado: (2018)

Astragalus Flavone Ameliorates Atherosclerosis and Hepatic Steatosis Via Inhibiting Lipid-Disorder and Inflammation in apoE(−/−) Mice
por: Ma, Chuanrui, et al.
Publicado: (2020)

Polyacetylene From Dendropanax morbifera Alleviates Diet-Induced Obesity and Hepatic Steatosis by Activating AMPK Signaling Pathway
por: Kang, Myung-Ji, et al.
Publicado: (2018)

Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats
por: Li, Mao, et al.
Publicado: (2016)

Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes
por: Jin, Chao, et al.
Publicado: (2022)

Fenofibrate Improves Insulin Resistance and Hepatic Steatosis and Regulates the Let-7/SERCA2b Axis in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice
por: Zhang, Dan, et al.
Publicado: (2022)

Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice
por: Chang, Ting-Chen, et al.
Publicado: (2019)

Corrigendum: Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes
por: Jin, Chao, et al.
Publicado: (2023)

Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity
por: Kern, Matthias, et al.
Publicado: (2012)

Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance
por: Qiao, Lu, et al.
Publicado: (2022)

Phyllanthus emblica aqueous extract retards hepatic steatosis and fibrosis in NAFLD mice in association with the reshaping of intestinal microecology
por: Luo, Xiaomin, et al.
Publicado: (2022)

Zinc Oxide Nanoparticle Caused Plasma Metabolomic Perturbations Correlate with Hepatic Steatosis
por: Zhang, Weidong, et al.
Publicado: (2018)

Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice
por: Ardaiz, Nuria, et al.
Publicado: (2021)

Dendrobium Officinale Polysaccharide Attenuates Insulin Resistance and Abnormal Lipid Metabolism in Obese Mice
por: Qu, Jian, et al.
Publicado: (2021)

Sanye Tablet Ameliorates Insulin Resistance and Dysregulated Lipid Metabolism in High-Fat Diet-Induced Obese Mice
por: Yao, Minghe, et al.
Publicado: (2021)

The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism
por: Li, Sha, et al.
Publicado: (2020)

Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals
por: Mercer, Emileigh, et al.
Publicado: (2012)

Hydroxychloroquine-induced Retinal Toxicity
por: Yusuf, Imran H., et al.
Publicado: (2023)

Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury via Improving Metabolic Reprogramming in Chronic Alcohol-Fed Mice
por: Pi, Aiwen, et al.
Publicado: (2021)

Genetic regulation of liver lipids in a mouse model of insulin resistance and hepatic steatosis
por: Norheim, Frode, et al.
Publicado: (2021)

Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro
por: Li, Ting, et al.
Publicado: (2021)

Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns
por: Su, Zuqing, et al.
Publicado: (2019)

Metformin Alleviates Hepatic Steatosis and Insulin Resistance in a Mouse Model of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Promoting Transcription Factor EB-Dependent Autophagy
por: Zhang, Dan, et al.
Publicado: (2021)

Hepatic glucose utilization in hepatic steatosis and obesity
por: Keramida, Georgia, et al.
Publicado: (2016)

Structural Characterization of Peptides From Huangjiu and Their Regulation of Hepatic Steatosis and Gut Microbiota Dysbiosis in Hyperlipidemia Mice
por: Shi, Ying, et al.
Publicado: (2021)

Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis
por: Radlinger, Bernhard, et al.
Publicado: (2022)

Insulin resistance, steatosis and hepatitis C virus
por: Mangia, Alessandra, et al.
Publicado: (2013)

Hepatitis C Virus, Insulin Resistance, and Steatosis
por: Kralj, Dominik, et al.
Publicado: (2016)

Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice
por: Krumm, Christopher S., et al.
Publicado: (2021)

Editorial: Hepatic insulin resistance and related obesity: highlighting the ameliorative role of nutraceuticals, dietary intervention, and pharmaceuticals
por: Ramadan, Nehal M., et al.
Publicado: (2023)

Hydroxychloroquine as Prophylaxis for COVID-19: A Review
por: Monti, Manuela, et al.
Publicado: (2020)

Hydroxychloroquine in COVID-19 Patients: Pros and Cons
por: Younis, Nour K., et al.
Publicado: (2020)

Hepatic Proteomic Changes and Sirt1/AMPK Signaling Activation by Oxymatrine Treatment in Rats With Non-alcoholic Steatosis
por: Xu, Hong, et al.
Publicado: (2020)

Development of Prediction Models for Drug-Induced Cholestasis, Cirrhosis, Hepatitis, and Steatosis Based on Drug and Drug Metabolite Structures
por: Shin, Hyun Kil, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0lgjujbibho8t92bj31oipq3od